United Therapeutics Corporation (UTHR)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 6,444,000 | 6,100,900 | 5,697,200 | 5,338,100 | 5,984,800 | 5,712,100 | 5,411,000 | 5,123,200 | 4,796,700 | 4,562,200 | 4,318,400 | 4,176,300 | 3,958,900 | 3,829,700 | 3,639,500 | 3,445,400 | 3,395,200 | 3,283,100 | 3,093,700 | 2,948,500 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $6,444,000K
= 0.00
The debt-to-equity ratio for United Therapeutics Corporation has consistently been 0.00 across all reported periods from March 31, 2020, to December 31, 2024. This ratio indicates that the company has not been relying on debt to finance its operations and growth, as its debt levels are either minimal or non-existent compared to its equity. A low or zero debt-to-equity ratio is generally considered favorable as it suggests a lower financial risk and a strong financial position for the company. In United Therapeutics' case, the consistent 0.00 ratio reflects a prudent capital structure that minimizes the potential financial risks associated with high levels of debt, which may be viewed positively by investors and creditors alike.
Peer comparison
Dec 31, 2024